Search
report cover1

Global Transcatheter Embolization and Occlusion Devices Market “(By Product Type: (Coiled Type: Pushable Coil & Detachable Coil),(Non -Coiled Type: Embolization Particle, Flow Diverter devices, Liquid embolic & others), (By Application type: Peripheral vascular diseases(Arterial blockage, venous blood clot &others), (Oncology: Liver Cancer, Kidney Cancer, Pancreatic Cancer, Breast Cancer & others), (Urology: Urinary retention/Benign Prostatic Hyperplasia & others), (Neurology: Brain Aneurysm, Cerebral arteriovenous Malformation & others), (By End-user: Hospitals, Ambulatory Surgical Centers, Clinics & Others), (Based on Region: North America, Europe, Asia -Pacific, Latin America, Middle East & Africa)" - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2030

A prominent research firm, Cognizance Market Research added a cutting-edge industry report on the “Global Transcatheter Embolization and Occlusion Devices Market”. The report studies the current as well as past growth trends and opportunities for the market to gain valuable insights during the forecast period from 2022 to 2030.

Global Transcatheter Embolization and Occlusion Devices Market Analysis

According to cognizance market research, the Global Transcatheter Embolization and Occlusion Devices Market was valued at US$ 3,198.3 Million in 2022 and is anticipated to reach US$ 6,306.2 Million by the end of 2030 with a CAGR of 8.9% from 2023 to 2030.

transcatheter embolization and occlusion devices market

What is the Global Transcatheter Embolization and Occlusion Devices Market?

A synthetic embolus is inserted through a tiny catheter into the blood vessel to impede blood flow to the tumor or other specific locations in the body in transcatheter embolization and occlusion, a minimally invasive procedure used in interventional radiology. To block small blood arteries, liquid-suspended particles such as gelatine-impregnated acrylic sphere polymer and polyvinyl alcohol (PVA) are injected into the bloodstream. Coils are eternal embolic devices that come in a variety of sizes and shapes, and they are coated with chemotherapeutic medications that cause cytotoxicity to attack the tumor and obstruct the blood supply.

These procedures also aid in removing improper connections between the arterial and venous systems and in preventing or controlling abnormal bleeding. Moreover, they aid in the management of aneurysms. Unlike open and invasive surgical techniques, transcatheter embolization is particularly effective at controlling bleeding without being invasive. The use of TEO devices is another area where this technology is becoming more widely adopted. Embolization particles and liquid embolic, which are non-coil products, aid minimally invasive surgery. Hence, using these devices helps prevent issues like catheter entrapment, inaccurate installation, and balloon deflation brought on by coiling. To take advantage of these benefits, surgeons are increasingly moving toward non-coil devices, which are expected to increase revenue for TEO devices.

Transcatheter embolization is a useful therapeutic option for many gynecological and obstetric problems. It is feasible to avoid surgery with minimally invasive transcatheter embolization procedures, which reduce mortality and morbidity while preserving a patient’s possibility for future conception. Under the guidance of knowledgeable interventional radiologists and with essential technological support, transcatheter embolization is utilized to cure a range of ulcerations in the female pelvis, such as ectopic pregnancy, arteriovenous malformation, and advanced-stage cancer. It is used to treat pelvic congestion syndrome and uterine fibroid symptoms after women have undergone the necessary examination. Success rates of 85% and higher have been recorded for women receiving embolization to treat uterine polyps.

Global Transcatheter Embolization and Occlusion Devices Market Outlook

In the ever-evolving world of medical technology, the industry for transcatheter embolization and occlusion devices is witnessing a remarkable journey. It’s a tale of innovation and challenges, with its plot driven by several key factors.

At the heart of this story are the transcatheter embolization and occlusion devices themselves, designed with precision to offer increased efficiency and a wide range of products. These include flow diverters, accessories, liquid embolic agents, embolization coils, and many others, all tailored to carry out vital tasks with effectiveness. As the demand for minimally invasive procedures grows, transcatheter techniques have gained significant traction, replacing older methods like clipping with coiling. This shift has fueled the market’s expansion, as more healthcare professionals and patients embrace the advantages of these innovative devices.

However, no story is without its challenges. High production costs loom as a potential impediment to the market’s growth, threatening the affordability and accessibility of these life-saving technologies. Stringent regulatory environments add another layer of complexity, making it crucial for manufacturers to navigate these hurdles while delivering cutting-edge solutions. Additionally, the rising prevalence of chronic diseases worldwide casts a shadow over the healthcare landscape, adding urgency to the need for transcatheter embolization and occlusion devices.

Yet, amidst these challenges, there are rays of hope. The benefits of minimally invasive treatments, an aging population, and increased healthcare spending promise a brighter future for the industry. Moreover, innovations in the healthcare sector and the burgeoning field of medical tourism present new opportunities for market participants.

Nonetheless, the path to success is not without its obstacles. A shortage of specialists with the necessary skills to perform these procedures effectively and a persistently high rate of surgical errors weigh on the industry’s growth prospects. Lesions and complications pose a constant threat, demanding continuous improvement and adaptation from the medical community.

The tale takes an unexpected turn with the arrival of COVID-19. The pandemic sent shockwaves through the healthcare industry, but transcatheter embolization and occlusion devices remained resilient. The surge in medical product sales was met with an equally determined medical supply sector. As COVID-19 cases surged, so did the demand for respiratory support equipment and life-saving machines. Industry leaders rose to the occasion, ensuring the availability of critical medical supplies despite the challenges posed by the pandemic.

In the end, the market of transcatheter embolization and occlusion devices is one of perseverance and progress. It’s a tale of a dynamic industry, driven by innovation, adapting to challenges, and emerging stronger in the face of adversity. As the world continues to change, this narrative will undoubtedly evolve, with new chapters yet to be written in the ongoing saga of medical advancement.

Segment Analysis:

The market for transcatheter embolization and occlusion devices is divided into segments based on product, application, end-user, and geographic location. The development of these segments will assist you in analyzing the industries’ sparsely growing segments and will give users useful industry understanding and market knowledge to aid in the selection of key market applications.

The global transcatheter embolization and occlusion devices market based on products is segmented into Coiled types and non-coiled types. Under coiled types, there are pushable coils and detachable coils. For non-coiled types, the segments include Embolization particles, flow diverter devices, liquid embolic, and others. In terms of product, the non-Coiled segment of the market accounted for the largest share of the global market for transcatheter embolization and occlusion devices by 2022. The usage of these devices has been credited with the quick expansion of this product category since it helps prevent issues including, balloon deflation, inaccurate installation, and catheter entrapment, brought on by coiling. To take advantage of the advantages associated with non-coil devices, surgeons are turning more and more toward them. Hence, the market for transcatheter embolization and occlusion devices benefits from the rising demand for illness treatment.

Based on application, the global transcatheter embolization and occlusion devices market is segmented into peripheral vascular diseases (Arterial blockage, venous blood clot & others), Oncology (Liver cancer, kidney cancer, Pancreatic cancer, breast cancer & others), Urology (Urinary retention/benign prostatic Hyperplasia & others), and Neurology (Brain Aneurysm, Cerebral arteriovenous Malformation, & others). Over the projection period, peripheral vascular disease is expected to be a very lucrative segment. Due to a growth in the number of elderly people, changing lifestyles that have resulted in a high rate of obesity, and an increase in the need for minimally invasive procedures, the category is anticipated to continue to dominate the market from 2022 to 2030. However, due to the rising incidence of cancer around the world, the oncology category is anticipated to grow at a rapid pace during the forecast period.

Based on end-users, the global transcatheter embolization and occlusion devices market is segmented into Hospitals, Ambulatory surgical centers, clinics and others. In 2022, the hospital sector accounted for a sizable portion of the global market. The expansion of the hospital market can be related to the accessibility of various service alternatives, devices, and partnerships with healthcare organizations to improve the range of healthcare goods and services. In addition, hospitals are the favored option since they have better medical services and access to cutting-edge technology. Due to an increase in the number of elderly people and a rise in the infrastructure and support for health care, the hospital market is anticipated to grow at a rapid CAGR, particularly in developed nations. Also, the market is projected to be driven by a rising need for transcatheter embolization and occlusion devices in ambulatory surgery centers during medical emergencies.

Geographical Analysis:

The global market for transcatheter embolization and occlusion devices is divided into regional segments, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, Europe ranked second after North America as the market leader for transcatheter embolization and occlusion devices.

The market in North America is driven by the region’s highly developed healthcare system, increasing provider awareness about transcatheter embolization and occlusion devices, and ongoing advancements in these technologies. In 2022, North America and Europe collectively represented most of the revenue. Some of the factors fueling the demand for TEO devices in these regions include the presence of a modern, well-defined regulatory framework, a robust healthcare infrastructure, and skilled healthcare personnel to perform the operations. It is expected that both regions will continue to dominate throughout the predicted period.

The transcatheter embolization and occlusion equipment market in the Asia Pacific is anticipated to grow rapidly during the forecast period due to the increasing awareness of transcatheter embolization and occlusion devices for medical reasons. Additionally, the healthcare industry’s growth in countries like China, Japan, and India presents significant opportunities for the region. Technological improvements and an increase in the rate of implementation of transcatheter embolization and occlusion device products are expected to drive the market in the area throughout the forecast period.

In summary, while North America and Europe currently lead the global market for transcatheter embolization and occlusion devices, the Asia Pacific region is poised for rapid growth due to increasing awareness and advancements in healthcare infrastructure and technology. These regional dynamics highlight the global expansion and significance of transcatheter embolization and occlusion devices in the medical field.

geographical analysis

The report offers the revenue of the global transcatheter embolization and occlusion devices market for the period 2020-2030, considering 2020 and 2021 as historical years, 2022 as the base year, and 2023 to 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global transcatheter embolization and occlusion devices market for the forecast period. The global transcatheter embolization and occlusion devices market report provides insights and in-depth analysis into developments impacting enterprises and businesses on a regional and global level. The report covers the global transcatheter embolization and occlusion devices market performance in terms of revenue contribution from several segments and comprises a detailed analysis of key drivers, trends, restraints, and opportunities prompting revenue growth of the global transcatheter embolization and occlusion devices market.

The report has been prepared after wide-ranging secondary and primary research. Secondary research included internet sources, numerical data from government organizations, trade associations, and websites. Analysts have also employed an amalgamation of bottom-up and top-down approaches to study numerous phenomena in the global transcatheter embolization and occlusion devices market. Secondary research involved a detailed analysis of significant players’ product portfolios. Literature reviews, press releases, annual reports, white papers, and relevant documents have also been studied to understand the global transcatheter embolization and occlusion devices market. Primary research involved a great extent of research efforts, wherein experts carried out interviews telephonic as well as questioner-based with industry experts and opinion-makers.

The report includes an executive summary, along with a growth pattern of different segments included in the scope of the study. The Y-o-Y analysis with elaborate market insights has been provided in the report to comprehend the Y-o-Y trends in the global transcatheter embolization and occlusion devices market. Additionally, the report focuses on altering competitive dynamics in the global market. These indices serve as valued tools for present market players as well as for companies interested in participating in the global transcatheter embolization and occlusion devices market. The subsequent section of the transcatheter embolization and occlusion devices report highlights the USPs, which include key industry events (product launch, research partnership, acquisition, etc.), technology advancements, pipeline analysis, prevalence data, and regulatory scenario.

 Global Transcatheter Embolization and Occlusion Devices Market Competitive Landscape

There are numerous international and regional players in the highly fragmented market for transcatheter embolization and occlusion devices. The top companies in the global market for transcatheter embolization and occlusion devices are.

  • BTG plc
  • Boston Scientific Corporation
  • Medtronic plc
  • Penumbra, Inc.
  • Cook Medical
  • Edwards Lifesciences Corporation
  • Merit Medical Systems
  • Johnson & Johnson Services, Inc.
  • Pfizer, Inc.
  • Stryker Corporation
  • Terumo Corporation
  • Sirtex Medical Limited
  • Abbott Laboratories.

The report explores the competitive scenario of the transcatheter embolization and occlusion devices market. Major players operating in the transcatheter embolization and occlusion devices market have been identified and profiled for unique commercial attributes. Company overview (company description, product portfolio, geographic presence, employee strength, Key management, etc.), financials, SWOT analysis, recent developments, and key strategies are some of the features of companies profiled in the transcatheter embolization and occlusion devices market report.

Segmentation:

 Global Transcatheter Embolization and Occlusion Devices Market, By Product Type

  • Coiled Type
    • Pushable Coil
    • Detachable coil
  • Non-coiled type
    • Embolization particle
    • Flow diverter devices
    • Liquid embolic
    • others
  • Transcatheter

    Global Transcatheter Embolization and Occlusion Devices Market, By Application

  • Peripheral Vascular diseases
    • Arterial blockage
    • Venous blood clot
    • Others
  • Oncology
    • Liver Cancer
    • Kidney Cancer
    • Pancreatic Cancer
    • Breast Cancer
    • Others
  • Urology
    • Urinary Retention/Benign Prostatic Hyperplasia
    • Others
  • Neurology
    • Brain Aneurysm
    • Cerebral arteriovenous Malformation
    • Others

Global Transcatheter Embolization and Occlusion Devices Market, By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • others

Global Transcatheter Embolization and Occlusion Devices Market, By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of the Middle East & Africa
Complete the form below and we'll get back to you shortly
Table of Content

Research Methodology: Aspects

Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.

The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.

Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.

Key phases involved in in our research process are mentioned below:

slide1

Understanding Clients’ Objectives:

Extensive Discussions and Consultations:

  • We initiate in-depth discussions and consultations with our clients to gain a comprehensive understanding of their objectives. This involves actively listening to their needs, concerns, and aspirations regarding the research project.
  • Through these interactions, we aim to uncover the underlying motivations driving their research requirements and the specific outcomes they hope to achieve.

Industry and Market Segment Analysis:

  • We invest time and effort in comprehensively understanding our clients’ industry and market segment. This involves conducting thorough research into market trends, competitive dynamics, regulatory frameworks, and emerging opportunities or threats.
  • By acquiring a deep understanding of the broader industry landscape, we can provide context-rich insights that resonate with our clients’ strategic objectives.

Target Audience Understanding:

  • We analyze our clients’ target audience demographics, behaviors, preferences, and needs to align our research efforts with their consumer-centric objectives. This entails segmenting the audience based on various criteria such as age, gender, income level, geographic location, and psychographic factors.
  • By understanding the nuances of the target audience, we can tailor our research methodologies to gather relevant data that illuminates consumer perceptions, attitudes, and purchase intent.

slide2

Identifying Challenges and Opportunities:

  • We proactively identify the challenges and opportunities facing our clients within their respective industries. This involves conducting SWOT (Strengths, Weaknesses, Opportunities, Threats) analyses and competitive benchmarking exercises.
  • By identifying potential obstacles and growth drivers, we can provide strategic recommendations that help our clients navigate complexities and capitalize on emerging opportunities effectively.

Grasping Specific Goals:

  • We delve into the intricacies of our clients’ objectives to gain clarity on the specific goals they aim to accomplish through the research. This entails understanding their desired outcomes, such as market expansion, product development, or competitive analysis.
  • By gaining a nuanced understanding of our clients’ goals, we can tailor our research approach to address their unique challenges and opportunities effectively.

Data Collection:

slide3

Primary Research Process:

  • Surveys: We design and administer surveys tailored to capture specific information relevant to our clients’ objectives. This may involve employing various survey methodologies, such as online, telephone, or face-to-face interviews, to reach target audiences effectively.
  • Interviews: We conduct structured or semi-structured interviews with key stakeholders, industry experts, or target consumers to gather in-depth insights and perspectives on relevant topics. These interviews allow us to probe deeper into specific issues and uncover valuable qualitative data.
  • Focus Groups: We organize focus group discussions with carefully selected participants to facilitate interactive discussions and gather collective opinions, attitudes, and preferences. This qualitative research method provides rich contextual insights into consumer behaviors and perceptions.
  • Observations: We conduct observational research by directly observing consumer behaviors, interactions, and experiences in real-world settings. This method enables us to gather objective data on consumer actions and reactions without relying on self-reported information.

Secondary Research Process:

  • Literature Review: We conduct comprehensive literature reviews to identify existing studies, academic articles, and industry reports relevant to the research topic. This helps us gain insights into previous research findings, theoretical frameworks, and best practices.
  • Industry Reports: We analyze industry reports published by reputable trade associations (whitepapers, research studies, etc.), and government agencies (U.S. Census Bureau, Bureau of Labor Statistics, and Securities and Exchange Commission etc.) to obtain macro-level insights into market trends, competitive landscapes, and industry dynamics.
  • Government Publications: We review government publications, such as economic reports, regulatory documents, and statistical databases, to gather relevant data on demographics, market size, consumer spending patterns, and regulatory frameworks.
  • Online Databases: We leverage online databases, such as industry portals, and academic repositories (PubMed Central (PMC), ScienceDirect, SSRN (Social Science Research Network), Directory of Open Access Journals (DOAJ), NCBI, etc.), to access a wide range of secondary data sources, including market statistics, financial data, and industry analyses.

slide4

slide5

 

 

Data Analysis:

The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.

slide6

 

Transformation of Raw Data:

  • Upon collecting the necessary data, we transition into the data analysis phase, where raw data is processed and transformed into actionable insights. This involves organizing, cleaning, and structuring the data to prepare it for analysis.

Utilization of Analytical Methods:

  • Depending on the research objectives, we employ a diverse range of analytical methods to extract meaningful insights from the data. These methods include statistical analysis, trend analysis, regression analysis, and qualitative coding.

Statistical Analysis:

  • Statistical tools are instrumental in uncovering patterns, correlations, and trends within the data. By applying statistical techniques such as descriptive statistics, hypothesis testing, and multivariate analysis, we can discern relationships and derive valuable insights.

Qualitative Analysis Techniques:

  • In addition to quantitative analysis, we leverage qualitative analysis techniques to gain deeper insights from qualitative data sources such as interviews or open-ended survey responses. One such technique is thematic coding, which involves systematically categorizing and interpreting themes or patterns within qualitative data.

Integrity and Validity Maintenance:

  • Throughout the analysis process, we maintain a steadfast commitment to upholding the integrity and validity of our findings. This entails rigorous adherence to established methodologies, transparency in data handling, and thorough validation of analytical outcomes.

Data Validation:

The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.

slide7

Importance of Data Validation:

  • Data validation is the final phase of the research methodology, crucial for ensuring the reliability and credibility of the findings. It involves a systematic process of reviewing and verifying the collected data to detect any inconsistencies, errors, or biases.

Scrutiny of Collected Data:

  • The validation process begins with a thorough scrutiny of the collected data to identify any discrepancies or anomalies. This entails comparing data points, checking for outliers, and verifying the accuracy of data entries against the original sources.

Validation Techniques:

  • Various validation techniques are employed to ensure the accuracy and integrity of the data. These include cross-referencing data from multiple sources to corroborate findings, conducting validity checks on survey instruments to assess the reliability of responses, and seeking feedback from independent experts or peer reviewers to validate the interpretation of results.

Internal Quality Assurance Protocols:

  • In addition to external validation measures, internal quality assurance protocols are implemented to further validate the accuracy of the analysis. This may involve conducting internal audits, peer reviews, or data validation checks to ensure that the research process adheres to established standards and guidelines.

Report Scope:

Attribute

Description

Market Size

US$ 6,306.2 Million (2030)

Compound Annual Growth Rate (CAGR)

8.90%

Base Year

2022

Forecast Period

2023-2030

Forecast Units

Value (US$ Million)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Geographies Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Countries Covered

U.S., Canada, Germany, U.K., France, Spain, Italy, Rest of Europe, Japan, China, India, Australia & New Zealand, South Korea, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, GCC, South Africa, Rest of Middle East & Africa

Key Companies Profiled

BTG plc, Boston Scientific Corporation, Medtronic plc, Penumbra, Inc., Cook Medical, Edwards Lifesciences Corporation, etc.

Key Questions Answered in Transcatheter Embolization and Occlusion Devices Market Report

BTG plc, Boston Scientific Corporation, Medtronic plc, Penumbra, Inc., Cook Medical, Edwards Lifesciences Corporation, etc.

Trend: a paradigm shift from clipping to coiling, increasing adoption of this technique, etc., drivers: rising demand for minimally invasive surgeries, transcatheter devices with the usage of radiology eliminated the surgeries, patient awareness, etc., Opportunities: increased prevalence of cancer & development in oncology treatment, a wide range of devices reduces the rate of surgeries, etc., challenges: Costly products, stringent regulatory approval procedure, etc.

North America and Europe

Expansion of product portfolio, acquisition & and merges, etc.

BTG plc, Boston Scientific Corporation, Medtronic plc, Penumbra, Inc., Cook Medical, Edwards Lifesciences Corporation, etc.

Goodbye 2024: Special Year-End Sale!

US$ 4600.00

Single User - $2300.00

It allows one person, the buyer, to have the sole rights and access to the purchased report. Further distribution of the product is strictly prohibited.

US$ 6500.00

Team User - $3250.00

It allows the purchased product to be shared among 1-7 employees of your organization within the same geographical location.

US$ 8500.00

Corporate User - $4250.00

It allows the purchased product to be shared among all employees of your organization irrespective of their geographical location.

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png
Complete the form below and we'll get back to you shortly
Customization
small c popup.png
Complete the form below and we'll get back to you shortly
Discount
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert